Impact of Injection Speed, Volume, and Site on Pain Sensation

Journal of Diabetes Science and Technology

Volumn 12, Issue 1, 2018, Pages 163-168

  Zijlstra, Eric ^a   Jahnke, Johannes ^b   Fischer, Annelie ^a   Kapitza, Christoph ^a   Forst, Thomas ^b  

^a Profil   (Germany)

^b Profil Mainz   (Germany)

Author keywords

diabetes; dosing accuracy; injection pain; insulin pen; subcutaneous injection

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; EXPERIMENTAL STUDY; FEMALE; HUMAN; INJECTION SITE PAIN; INJECTION SPEED; INJECTION VOLUME; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL ANALOG SCALE; ABDOMEN; INJECTION SITE REACTION; PAIN; PAIN MEASUREMENT; SUBCUTANEOUS DRUG ADMINISTRATION; THIGH;

ABDOMEN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INJECTION SITE REACTION; INJECTIONS, SUBCUTANEOUS; PAIN; PAIN MEASUREMENT; THIGH;

EID: 85042079509     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296817735121     Document Type: Article

References (23)

1. Zijlstra E, Heinemann L, Plum-Morschel L., Oral insulin reloaded: a structured approach. J Diabetes Sci Technol. 2014;8(3):458-465.
2. Heinemann L, Jacques Y., Oral insulin and buccal insulin: a critical reappraisal. J Diabetes Sci Technol. 2009;3(3):568-584.
3. Shah RB, Patel M, Maahs DM, Shah VN., Insulin delivery methods: past, present and future. Int J Pharm Investig. 2016;6(1):1-9.
4. Marcus A., Diabetes care—insulin delivery in a changing world. Medscape J Med. 2008;10(5):120.
5. Slabaugh SL, Bouchard JR, Li Y, Baltz JC, Meah YA, Moretz DC., Characteristics relating to adherence and persistence to basal insulin regimens among elderly insulin-naive patients with type 2 diabetes: pre-filled pens versus vials/syringes. Adv Ther. 2015;32(12):1206-1221.
6. Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B., Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014;20(6):536-539.
7. Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O., Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2013;15(3):230-236.
8. Ayyagari R, Wei W, Cheng D, Pan C, Signorovitch J, Wu EQ., Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment. Value Health. 2015;18(2):198-205.
9. Aronson R., The role of comfort and discomfort in insulin therapy. Diabetes Technol Ther. 2012;14(8):741-747.
10. Glynn CJ, Lloyd JW., The diurnal variation in perception of pain. Proc R Soc Med. 1976;69(5):369-372.
11. Laursen T, Hansen B, Fisker S., Pain perception after subcutaneous injections of media containing different buffers. Basic Clin Pharmacol Toxicol. 2006;98(2):218-221.
12. Norman JJ, Prausnitz MR., Improving patient acceptance of insulin therapy by improving needle design. J Diabetes Sci Technol. 2012;6(2):336-338.
13. Arendt-Nielsen L, Egekvist H, Bjerring P., Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37-43.
14. Egekvist H, Bjerring P, Arendt-Nielsen L., Pain and mechanical injury of human skin following needle insertions. Eur J Pain. 1999;3(1):41-49.
15. Heise T, Nosek L, Dellweg S. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial. Diabetes Obes Metab. 2014;16(10):971-976.
16. World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
17. Præstmark KA, Stallknecht B, Jensen ML, Sparre T, Madsen NB, Kildegaard J., Injection technique and pen needle design affect leakage from skin after subcutaneous injections. J Diabetes Sci Technol. 2016;10(4):914-922.
18. Jensen MP, Engel JM, McKearnan KA, Hoffman AJ., Validity of pain intensity assessment in persons with cerebral palsy: a comparison of six scales. J Pain. 2003;4(2):56-63.
19. Thomsen M, Rasmussen CH, Refsgaard HH. Spatial distribution of soluble insulin in pig subcutaneous tissue: effect of needle length, injection speed and injected volume. Eur J Pharm Sci. 2015;79:96-101.
20. Zaybak A, Khorshid L., A study on the effect of the duration of subcutaneous heparin injection on bruising and pain. J Clin Nurs. 2008;17(3):378-385.
21. Wittmann A, Kover J, Kralj N. Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther. 2010;12(8):587-590.
22. Ignaut DA, Fu H., Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus. J Diabetes Sci Technol. 2012;6(2):389-393.
23. Bailey TS., Analysis and perspective: comparison of insulin diluent leakage post-injection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus. J Diabetes Sci Technol. 2012;6(2):394-395.